Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer

Pomalidomide is a distinct immunomodulatory agent that also displays anti-proliferative and proapoptotic activity. The purpose of this study was to assess the efficacy and safety of pomalidomide for the treatment of chemotherapy-naïve patients with metastatic castration-resistant prostate cancer (CR...

Descripción completa

Detalles Bibliográficos
Autores principales: Amato, Robert J., Glode, L. Michael, Podolnick, Jeremy, Knight, Robert, Crawford, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759205/
https://www.ncbi.nlm.nih.gov/pubmed/24212963
http://dx.doi.org/10.3390/cancers3033449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759205/
https://www.ncbi.nlm.nih.gov/pubmed/24212963
http://dx.doi.org/10.3390/cancers3033449

Ejemplares similares